+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Silent Cancer Drugs"

From
From
From
From
From
From
From
From
From
From
From
From
From
From
  • 15 Results (Page 1 of 1)
Loading Indicator

The Silent Cancer Drugs market is a subset of the Oncology Drugs market, focusing on drugs that are used to treat cancer without causing any noticeable side effects. These drugs are designed to target cancer cells without damaging healthy cells, allowing patients to receive treatment without the debilitating side effects of traditional chemotherapy. Silent Cancer Drugs are typically administered orally or intravenously, and can be used to treat a variety of cancers, including breast, lung, and prostate cancer. Silent Cancer Drugs are becoming increasingly popular due to their effectiveness and lack of side effects. They are also often more affordable than traditional chemotherapy drugs, making them a viable option for many patients. Some companies in the Silent Cancer Drugs market include AbbVie, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more